Filana Therapeutics (SAVA) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.92
-0.69
-0.45
-0.22

Details

Expected EPS
-0.27
Actual EPS
-0.22
Surprise EPS
0.05
Surprise Percent
+18.52%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.22 per share for Q4 2025.

0 Comments

Share your thoughts